Oxolamine: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (changes to watched fields - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or bugs) |
Rescuing 3 sources and tagging 0 as dead.) #IABot (v2.0.9.5 |
||
(27 intermediate revisions by 19 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Cough suppressant}} |
|||
{{Drugbox |
{{Drugbox |
||
| |
| Verifiedfields = changed |
||
| verifiedrevid = |
| verifiedrevid = 447812881 |
||
| IUPAC_name = N,N-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanamine |
| IUPAC_name = N,N-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanamine |
||
| image = Oxolamine.png |
| image = Oxolamine.png |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| Drugs.com = {{drugs.com|international|oxolamine}} |
| Drugs.com = {{drugs.com|international|oxolamine}} |
||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
||
| pregnancy_US = <!-- A / B / C / D / X --> |
| pregnancy_US = <!-- A / B / C / D / X --> |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
||
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
||
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 959-14-8 |
| CAS_number = 959-14-8 |
||
| ATC_prefix = R05 |
| ATC_prefix = R05 |
||
Line 31: | Line 33: | ||
| PubChem = 13738 |
| PubChem = 13738 |
||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = |
| DrugBank = DB13216 |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 13143 |
| ChemSpiderID = 13143 |
||
Line 38: | Line 40: | ||
| KEGG_Ref = {{keggcite|correct|kegg}} |
| KEGG_Ref = {{keggcite|correct|kegg}} |
||
| KEGG = D07387 |
| KEGG = D07387 |
||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|||
| ChEMBL = 1620875 |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=14 | H=19 | N=3 | O=1 |
| C=14 | H=19 | N=3 | O=1 |
||
| molecular_weight = 245.32 g/mol |
|||
| smiles = n1c(onc1c2ccccc2)CCN(CC)CC |
| smiles = n1c(onc1c2ccccc2)CCN(CC)CC |
||
| InChI = 1/C14H19N3O/c1-3-17(4-2)11-10-13-15-14(16-18-13)12-8-6-5-7-9-12/h5-9H,3-4,10-11H2,1-2H3 |
|||
| InChIKey = IDCHQQSVJAAUQQ-UHFFFAOYAF |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C14H19N3O/c1-3-17(4-2)11-10-13-15-14(16-18-13)12-8-6-5-7-9-12/h5-9H,3-4,10-11H2,1-2H3 |
| StdInChI = 1S/C14H19N3O/c1-3-17(4-2)11-10-13-15-14(16-18-13)12-8-6-5-7-9-12/h5-9H,3-4,10-11H2,1-2H3 |
||
Line 51: | Line 52: | ||
}} |
}} |
||
'''Oxolamine''' is a [[cough suppressant]]<ref>{{cite book | vauthors = de Groot AC | chapter = 3.357 Oxolamine |title=Systemic Drugs | series = Monographs in Contact Allergy | volume = 4 |date=2022 |publisher=CRC Press |isbn=978-1-00-054991-1 |page=712 |edition=First}}</ref> that is available as a [[generic drug]] in many jurisdictions.<ref>{{cite web | work = drugs.com | url = https://www.drugs.com/international/oxolamine.html | title = Oxolamine | date = 19 April 2015 | access-date = 23 January 2018 | archive-date = 20 September 2018 | archive-url = https://web.archive.org/web/20180920145016/https://www.drugs.com/international/oxolamine.html | url-status = live }}</ref> |
|||
'''Oxolamine''' is a [[cough suppressant]]. |
|||
Oxolamine also has [[anti-inflammatory]] activity, which causes a reduction in irritation of the nerve receptors of the [[respiratory tract]].<ref name=":0">{{Cite web |title=NCATS Inxight Drugs — OXOLAMINE CITRATE |url=https://drugs.ncats.io/drug/K5X4XBR694 |access-date=2022-09-26 |website=drugs.ncats.io |language=en |archive-date=2022-09-26 |archive-url=https://web.archive.org/web/20220926180401/https://drugs.ncats.io/drug/K5X4XBR694 |url-status=live }}</ref> |
|||
==Synthesis== |
|||
The syntheses of 1,2,4-[[oxadiazole]] systems all rely on [[hydroxylamine]] for providing a preformed N-O linkage. The preparation of the respiratory anti-inflammatory and antitussive agent oxolamine starts by [[acylation]] of the [[alkoxide]] from the N-hydroxyamidine with 3-chloropropionyl chloride; the presence of the negative charge on oxygen results in the formation of the O-acylated product. Treatment of that intermediate with [[triethylamine]] leads |
|||
to cyclization via imine formation to afford the 1,2,4-oxadiazole. Displacement of the terminal [[chlorine]] with [[diethylamine]] gives the corresponding amine oxolamine. |
|||
It is mainly used for the treatment of [[pharyngitis]], [[tracheitis]], [[bronchitis]], bronchiectasis and [[pertussis]].<ref name=":0" /> |
|||
[[File:Oxolamine rxn scheme.png|400px]] |
|||
Oxolamine is not approved in the USA, it may be marketed elsewhere internationally as a cough suppressant. It is listed as a [[prescription drug]] in New Zealand legislation. Oxolamine is also approved in Taiwan for the treatment of [[Respiratory tract infection|respiratory tract inflammation]].<ref>{{Cite web |title=Oxolamine |url=https://go.drugbank.com/drugs/DB13216 |access-date=2022-09-26 |website=go.drugbank.com |archive-date=2022-09-26 |archive-url=https://web.archive.org/web/20220926180403/https://go.drugbank.com/drugs/DB13216 |url-status=live }}</ref> |
|||
{{Cite patent|DE|1097998}} |
|||
==References== |
|||
{{reflist}} |
|||
{{Cough and cold preparations}} |
{{Cough and cold preparations}} |
||
Line 65: | Line 67: | ||
[[Category:Antitussives]] |
[[Category:Antitussives]] |
||
[[Category:Oxadiazoles]] |
[[Category:Oxadiazoles]] |
||
[[Category: |
[[Category:Diethylamino compounds]] |
||
{{respiratory-system-drug-stub}} |